Daniel Oehlrich

USPTO Granted Patents = 16 (Patent Applications = 19)

CIPO Patents = 8 (Patent Applications = 21)

EPO Patents = 16 (Patent Applications = 33)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 64(Granted Patents)

Location History:

Malle, BE (2014 - 2015)
Brecht, BE (2017)
Beerse, BE (2015 - 2018)
Geel, BE (2021)

Company Filing History:

11 out of 159

Janssen Pharmaceuticals, Inc.

patents

5 out of 2,078

Janssen Pharmaceutica Nv

where one patent can have more than one assignee

Years Active: 2014-2021

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11053248 - [1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors (2021-07-06),

2. 10071095 - 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders (2018-09-11),

3. 9840507 - 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE) (2017-12-12),

4. 9834559 - 4-Amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2H)-one derivatives as inhibitors of beta-secretase (BACE) (2017-12-05),

5. 9751886 - 4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE) (2017-09-05),

6. 9737533 - 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders (2017-08-22),

7. 9580433 - 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE) (2017-02-28),

8. 9271967 - 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors (2016-03-01),

9. 9226930 - 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders (2016-01-05),

10. 9145399 - Substituted bicyclic triazole derivatives as gamma secretase modulators (2015-09-29),

11. 9012448 - 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors (2015-04-21),

12. 8993591 - 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors (2015-03-31),

13. 8946426 - Substituted bicyclic heterocyclic compounds as gamma secretase modulators (2015-02-03),

14. 8946266 - Substituted triazole and imidazole derivatives as gamma secretase modulators (2015-02-03),

15. 8937060 - 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders (2015-01-20),

Title: The Innovative Journey of Daniel Oehlrich

Introduction:

Daniel Oehlrich, a talented inventor hailing from Beerse, Belgium, has made significant contributions to the field of innovation with his creative mind and dedication to problem-solving.

Latest Patents:

Daniel Oehlrich's latest patents include groundbreaking inventions in the medical device industry, focusing on improving patient outcomes and advancing healthcare technologies.

Career Highlights:

Throughout his career, Daniel Oehlrich has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His work has not only earned him recognition within the industry but has also positively impacted the lives of many individuals.

Collaborations:

Daniel Oehlrich has collaborated with leading research institutions and medical professionals to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Daniel Oehlrich's passion for innovation and commitment to excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire and drive positive change in various industries.

This text is generated by artificial intelligence and may not be accurate.